Aditya Rajagopal
Chairperson at Wisdom Biosciences
Mountain View, California
Overview
Work Experience
CEO, Chairman, Co-Founder
2018 - Current
Caltech spin-out utilizing compressed sensing methods with ultrasound to continuously and non-invasively measure blood pressure. Backed by Maverick Ventures and others.
Esperto's patented technology uses sound waves to measure blood pressure without an inflating cuff
Founder & Chairman
2012
We are a multiplexed molecular diagnostics company with a bioinformatics focus and pedigree from Google[x], Illumina, Luminex, and Caltech. We are transforming the multi-billion dollar molecular diagnostics industry by democratizing personalized medicine. I am the Founder and Member of the Board of Directors of ChromaCode, and the inventor of core technologies related to combinatorics for biochemical labeling, multiplexed PCR assay design, and algorithms for data processing. Served as CTO from 2012 - 2024.
ChromaCode is a molecular diagnostics company focusing on bioinformatics.
Raised $93,967,513.00 from Global Brain Corporation.
Chairperson
2024
Enabling dental offices with better patient diagnostics.
Independent Board Director
2020
Camena Bioscience utilizes novel "geometric synthesis" methods to build oligo nucleotides for synthetic biology with significantly higher length and purity. Advisor to Board of Directors and CEO (2020 - 2023) Independent Board Director (2023 - present)
Advisor
2022
Erisyon is commercializing the world’s first single molecule protein sequencer
Raised $225,000.00 from Musea Ventures.
Visiting Associate (Visiting Faculty)
2016
I lead, fund, and manage a research group working on interesting things at the nexus of biology, medicine, and engineering. HDPCR (commercialized by ChromaCode) is the first technology to be transitioned into industry from our lab. Compressed sensing with ultrasound (commercialized by Esperto Medical) is the second.
Adjunct Assistant Professor, Biomedical Engineering
2018
I work on interesting problems related to fluorescence imaging methods.
Advisor
2018 - 2024
LunaPBC is the first community-owned health and DNA data platform dedicated to advancing research through community engagement, and personal data ownership, control and transparency. Founded by former executive leadership from Illumina and funded by Illumina Ventures and Arch Ventures. Serve as an advisor to the founders of the company.
LunaPBC is a healthcare company that transforms health data into health breakthroughs.
Raised $11,443,707.00 from ARCH Venture Partners, Illumina Ventures, Bain Capital Ventures, F-Prime Capital and OUP (Osage University Partners).
Venture Partner
2020 - 2022
Investing at the nexus of data science, physical science, and life science. ND Capital investments include: Public: TWST, ARMO, SQZ Private: Visby, Inscripta
NanoDimension is a venture capital firm investing in disruptive technologies in and at the convergence of the life and physical sciences.
Visting Scholar, Canary Institute for Early Cancer Detection
2018 - 2020
Education
Doctor of Philosophy (PhD)
2008 - 2013
Master of Science (MS)
2008 - 2010
Bachelor of Science (BS)
2004 - 2008